I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 4 studies | 26% ± 13% | |
| astrocyte | 3 studies | 39% ± 18% | |
| interneuron | 3 studies | 40% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 4 studies | 26% ± 13% | |
| astrocyte | 3 studies | 39% ± 18% | |
| interneuron | 3 studies | 40% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 34% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| heart | 99% | 2986.97 | 853 / 861 | 0% | 0 | 0 / 0 |
| brain | 99% | 508.69 | 2603 / 2642 | 0% | 0.00 | 1 / 705 |
| blood vessel | 98% | 307.15 | 1310 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 97% | 256.88 | 174 / 180 | 0% | 0 | 0 / 430 |
| uterus | 96% | 249.49 | 163 / 170 | 0% | 0 | 0 / 459 |
| breast | 94% | 224.38 | 432 / 459 | 0% | 0.00 | 2 / 1118 |
| muscle | 93% | 176.92 | 748 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 93% | 183.11 | 240 / 258 | 0% | 0 | 0 / 230 |
| adipose | 92% | 229.44 | 1103 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 91% | 177.50 | 592 / 653 | 0% | 0 | 0 / 605 |
| prostate | 91% | 166.76 | 222 / 245 | 0% | 0 | 0 / 502 |
| spleen | 87% | 167.49 | 210 / 241 | 0% | 0 | 0 / 0 |
| bladder | 86% | 210.05 | 18 / 21 | 0% | 0 | 0 / 504 |
| lung | 85% | 149.07 | 493 / 578 | 0% | 0.00 | 2 / 1155 |
| intestine | 84% | 225.38 | 811 / 966 | 0% | 0 | 0 / 527 |
| kidney | 81% | 130.69 | 72 / 89 | 0% | 0.00 | 2 / 901 |
| esophagus | 71% | 198.67 | 1027 / 1445 | 0% | 0 | 0 / 183 |
| skin | 70% | 148.49 | 1273 / 1809 | 0% | 0 | 0 / 472 |
| stomach | 51% | 136.64 | 182 / 359 | 0% | 0 | 0 / 286 |
| pancreas | 14% | 14.14 | 47 / 328 | 0% | 0 | 0 / 178 |
| liver | 4% | 2.84 | 8 / 226 | 0% | 0 | 0 / 406 |
| peripheral blood | 2% | 1.45 | 14 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1903779 | Biological process | regulation of cardiac conduction |
| GO_0006468 | Biological process | protein phosphorylation |
| GO_0002027 | Biological process | regulation of heart rate |
| GO_0086069 | Biological process | bundle of His cell to Purkinje myocyte communication |
| GO_0055117 | Biological process | regulation of cardiac muscle contraction |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0004674 | Molecular function | protein serine/threonine kinase activity |
| GO_0106310 | Molecular function | protein serine kinase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005524 | Molecular function | ATP binding |
| GO_0004672 | Molecular function | protein kinase activity |
| Gene name | TNNI3K |
| Protein name | TNNI3 interacting kinase Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (Cardiac troponin I-interacting kinase) (TNNI3-interacting kinase) |
| Synonyms | CARK |
| Description | FUNCTION: May play a role in cardiac physiology. . |
| Accessions | ENST00000326637.8 [Q59H18-2] H0YDG1 ENST00000525480.2 Q59H18 H0YCE9 ENST00000526236.5 H0YE48 ENST00000534020.5 |
